Realm Therapeutics plc
Related Filers (4)
- BIOTECHNOLOGY VALUE FUND L P (2)
- Citibank,N.A./ADR (1)
- ORBIMED ADVISORS LLC (1)
- The Nasdaq Stock Market LLC (1)
- Show More ...
Other (54)
15-12B
Thursday, 8/1/2019
Notice of termination of registration of a class of securities under Section 12(b)
EFFECT
Wednesday, 7/31/2019
Notice of Effectiveness
25-NSE
Wednesday, 7/31/2019
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
6-K
Wednesday, 7/31/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 7/30/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
POS AM
Tuesday, 7/30/2019
Post-effective amendment to a registration statement that is not immediately effective upon filing
6-K
Friday, 7/19/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/8/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/5/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 7/2/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/26/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/24/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/11/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/29/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/16/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/10/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 4/10/2019
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Friday, 4/5/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 3/29/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/26/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 3/15/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/15/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/29/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/1/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Monday, 9/24/2018
Notice of Effectiveness
POS AM
Monday, 9/17/2018
Post-effective amendment to a registration statement that is not immediately effective upon filing
6-K
Monday, 9/17/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Wednesday, 8/22/2018
Notice of Effectiveness
POS AM
Wednesday, 8/22/2018
Post-effective amendment to a registration statement that is not immediately effective upon filing
6-K
Tuesday, 8/14/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 7/10/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CT ORDER
Thursday, 7/5/2018
Order Granting Confidential Treatment
EFFECT
Tuesday, 7/3/2018
Notice of Effectiveness
EFFECT
Tuesday, 7/3/2018
Notice of Effectiveness
F-1/A
Tuesday, 7/3/2018
Registration statement for securities of certain foreign private issuers
CORRESP
Tuesday, 7/3/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-6/A
Monday, 7/2/2018
Registration statement for American Depositary Receipts representing securities of certain foreign private issuers
F-6/A
Friday, 6/29/2018
Registration statement for American Depositary Receipts representing securities of certain foreign private issuers
F-1/A
Friday, 6/29/2018
Registration statement for securities of certain foreign private issuers
CORRESP
Friday, 6/29/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 6/21/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Tuesday, 6/19/2018
Registration statement for securities of certain foreign private issuers
CORRESP
Monday, 6/18/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Thursday, 6/14/2018
Registration statement for securities of certain foreign private issuers
CERT
Thursday, 6/14/2018
Certification by an exchange approving securities for listing
F-6/A
Wednesday, 6/13/2018
Registration statement for American Depositary Receipts representing securities of certain foreign private issuers
CORRESP
Wednesday, 6/13/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
8-A12B
Monday, 6/11/2018
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
F-6
Thursday, 5/31/2018
Registration statement for American Depositary Receipts representing securities of certain foreign private issuers
F-1/A
Wednesday, 5/30/2018
Registration statement for securities of certain foreign private issuers
F-1
Wednesday, 5/23/2018
Registration statement for securities of certain foreign private issuers
CORRESP
Tuesday, 5/22/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D/A
Wednesday, 10/25/2017
Exempt (Private) Offering
D
Tuesday, 10/17/2017
Exempt (Private) Offering
Ownership (3)
SC 13G/A
Thursday, 2/14/2019
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13D
Wednesday, 8/15/2018
ORBIMED ADVISORS LLC: Major Shareholders
SC 13G
Thursday, 7/19/2018
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
Prospectus (3)
424B4
Tuesday, 7/3/2018
Prospectus filed pursuant to Rule 424(b)(4)
DRS/A
Monday, 4/30/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Friday, 4/13/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy